Clinical Trials Logo

Brugada Syndrome Type 1 clinical trials

View clinical trials related to Brugada Syndrome Type 1.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT03572881 Not yet recruiting - Clinical trials for Brugada Syndrome Type 1

Rhythmic Risk of Type 1 Brugada Syndrome and Pulmonary Infundibulum Mapping

SB-CARTO
Start date: July 2018
Phase: N/A
Study type: Interventional

Brugada syndrome has been described as the association of a right bundle block with ST segment elevation on the V1 to V3 electrocardiogram in patients with a structurally normal heart. The rhythmic risk is thus difficult to evaluate in asymptomatic patients in whom the rate of events is estimated at 0.2 to 1.4% of events per year. In addition, the predictive value of ventricular pacing remains controversial; There is therefore currently no review to effectively assess rhythmic risk in patients with Brugada type I syndrome. Investigators aimed to show a difference in pulmonary infundibulum voltage mapping in symptomatic and asymptomatic patients with Brugada type 1 syndrome with a comparable ECG. The mapping of the pulmonary infundibulum will be performed during electrophysiological exploration. Only the catheter used differs from the usual procedure.